Skip to main content

Eosinophilic Asthma Clinical Trials in Oklahoma City

Clinical trials on eosinophilic asthma, where your involvement will contribute to better health outcomes.

Enroll Now

Asthma Leaving You Breathless?

You might qualify for eosinophilic asthma clinical trials

Eosinophilic asthma is a subtype of asthma characterized by elevated levels of eosinophils, a type of white blood cell, in the airways. These eosinophils play a key role in inflammation, leading to recurrent asthma symptoms such as wheezing, coughing, chest tightness, and shortness of breath.

At Hightower Clinical, we’re conducting clinical trials to find possible treatments for eosinophilic asthma. The study aims to assess an experimental drug’s safety, tolerability, and efficacy in individuals with cardiovascular diseases.

*Participation in the Clinical Trial is completely free of cost and is your choice.

**To participate, fill out the form, and someone from our research staff will call you to determine your eligibility for the Clinical Research Study.

About Eosinophilic Asthma Clinical Trials

In partnership with pharmaceutical companies, Hightower is conducting clinical trials for asthma to evaluate the tolerability, safety, and efficacy of an inhaler treatment for individuals with eosinophilic asthma symptoms.

This Phase 3 eosinophilic asthma research study aims to determine whether the investigational medication can effectively reduce e-asthma symptoms.

*All study procedures and study-related treatment, including the investigational drug, are free of cost, and insurance is not required to participate.

*The study doctor will take you through every step of the Clinical Trial before you decide to participate and will answer any questions you have about the study treatment.

Asthma Research: What to Expect?

Upon agreeing to participate in the study, you’ll be requested to sign an Informed Consent Form containing comprehensive details about the study. Our study team will also provide guidance on the study process and your role in the trials. We strongly encourage participants to ask any questions they may have before making their decision to participate or withdraw from the trial.

If you meet the criteria, you will be invited to the study location for screening, which will be within a 50-mile radius of your current location. The study doctors will advise you on the duration of the clinical trials for e-asthma and the implications of your involvement in this research study. After thoroughly explaining everything to the participants, they will be requested to sign an Informed Consent Form.

*Study-related care is offered at no charge. Expert physicians and healthcare professionals conduct thorough physical exams and assessments.


12 Years to 99 Years


Male & Female


Eosinophilic Asthma

Current Status


What are eosinophils, and what is their role in asthma?

Eosinophils are normally involved in fighting infections, but in eosinophilic asthma, their numbers become abnormally high in the airways. These extra eosinophils contribute to inflammation in the airways, leading to symptoms like wheezing, coughing, and shortness of breath.


  • Reduced Lung Function
  • Exacerbations
  • Chronic Rhinosinusitis
  • Nasal Polyps
  • Sleep Apnea
  • Otitis Media


  • Wheezing
  • Coughing, especially at night or early morning
  • Chest tightness
  • Shortness of breath

Frequently Asked Questions

What is eosinophilic asthma?

Eosinophilic asthma is a subtype of asthma characterized by elevated levels of eosinophils, a type of white blood cell, in the airways. It often presents with recurrent asthma symptoms and increased airway inflammation.

What are the risks of participating in an eosinophilic asthma clinical trial?

Like any medical intervention, participating in a clinical trial involves potential risks, including side effects from investigational treatments, discomfort from additional testing or procedures, and the possibility of treatment failure. Participants should discuss any concerns with the study team before enrolling.

How are participants monitored during eosinophilic asthma clinical trials?

Participants in eosinophilic asthma clinical trials undergo regular monitoring, including assessments of asthma symptoms, lung function tests, blood tests to measure eosinophil levels, and other relevant evaluations. Adverse events are closely monitored and managed according to the study protocol.